
CAS: 1219962-49-8
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | 3-[4-[6-[3-(Dimethylamino)propoxy]-1,3-benzoxazol-2-yl]phenoxy]-N,N-dimethylpropan-1-amine REF: 3D-UYB96249CAS: 1219962-49-8 | Min. 95% | A consultar | Mar 10 Jun 25 |
![]() | AT791 REF: TM-T61882CAS: 1219962-49-8 | 99.88% | 119,00 €~1.768,00 € | Mar 17 Jun 25 |

3-[4-[6-[3-(Dimethylamino)propoxy]-1,3-benzoxazol-2-yl]phenoxy]-N,N-dimethylpropan-1-amine
CAS:1219962-49-8
Please enquire for more information about 3-[4-[6-[3-(Dimethylamino)propoxy]-1,3-benzoxazol-2-yl]phenoxy]-N,N-dimethylpropan-1-amine including the price, delivery time and more detailed …
Fórmula:
C23H31N3O3
Pureza:
Min. 95%
Peso molecular:
397.5 g/mol
Ref: 3D-UYB96249
25mg | 1.063,00 € | ||
50mg | 1.478,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Junio de 2025

AT791
CAS:1219962-49-8
AT791 is an orally available TLR7 and TLR9 inhibitor, suppressing TLR7 and TLR9 signaling, used …
Fórmula:
C23H31N3O3
Pureza:
99.88%
Forma y color:
Liquid
Peso molecular:
397.51
Ref: TM-T61882
1mg | 119,00 € | ||
5mg | 283,00 € | ||
10mg | 467,00 € | ||
25mg | 870,00 € | ||
50mg | 1.130,00 € | ||
100mg | 1.768,00 € | ||
1mL*10mM (DMSO) | 281,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Junio de 2025